Understanding Off-Label Utilization Patterns of Two Biotechnology Drugs, Recombinant Erythropoietin Alfa and Darbepoetin Alfa: A Multi-Hospital Study
The American Medical Association (AMA) has estimated that as many as 40 percent of all prescriptions are issued for off-label use. Off-label prescribing is considered to be clinically beneficial and rational in certain life-threatening situations. However, off-label use can pose risks to patients in...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
VCU Scholars Compass
2005
|
| Subjects: | |
| Online Access: | http://scholarscompass.vcu.edu/etd_retro/47 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=1046&context=etd_retro |